SARS‐CoV‐2‐induced remission of Hodgkin lymphoma. Challenor, S. & Tucker, D. British Journal of Haematology, January, 2021.
SARS‐CoV‐2‐induced remission of Hodgkin lymphoma [link]Paper  doi  bibtex   
@article{challenor_sarscov2induced_2021,
	title = {{SARS}‐{CoV}‐2‐induced remission of {Hodgkin} lymphoma},
	issn = {0007-1048, 1365-2141},
	url = {https://onlinelibrary.wiley.com/doi/10.1111/bjh.17116},
	doi = {10.1111/bjh.17116},
	language = {en},
	urldate = {2021-01-25},
	journal = {British Journal of Haematology},
	author = {Challenor, Sarah and Tucker, David},
	month = jan,
	year = {2021},
	keywords = {Hodgkin lymphoma, SARS-CoV-2, SARS-CoV-2 immune response, cancer, immunotherapy},
	pages = {bjh.17116},
}

Downloads: 0